News | July 21, 2014

Texas' First Accredited Pediatric Heart Failure Institute Is Texas Children's Hospital

July 21, 2014 – The Healthcare Accreditation Colloquium announced that Texas Children's Hospital has earned the designation of Accredited Pediatric Heart Failure Institute following 12 months of work and an extensive onsite review. 
"The approach to heart failure at Texas Children's Hospital is one of the broadest ranging comprehensive programs in the U.S.," said Dr. Frank Smart, Colloquium Board Chair. "They care for the sickest children daily, yet remain committed to breakthrough research that has the potential to change medicine for everyone." 
The heart failure leadership team at Texas Children's Hospital worked in four domains to achieve heart failure accreditation: The Community, Hospital, Clinician, and Science. In the community their preventative screening program for sudden cardiac arrest in young people was especially notable. The hospital itself is an integrated small city where pediatric patients can actually go to an accredited classroom for their schooling while on ventricular assist devices and after heart transplantation. In the Clinician Domain, physician and nurse education is part of the institutional culture. Novel approaches to practical applications of science are everywhere. One example is the "Just in Time" scenario room where world-class clinicians can come together and practice possible clinical scenarios to prepare themselves anticipating emergencies before they take place.
"The Colloquium is about bringing together experts to improve heart failure care for children across the entire continuum of care," said Dr. Daniel J. Penny, chief of cardiology at Texas Children's Hospital. "We are delighted that Texas Children's is a recognized member of this expert group. We look forward to working with The Colloquium wherever children with heart failure have a need." 
The Colloquium is the first organization to develop an improvement science based approach to pediatric heart failure accreditation. Member hospitals conduct the site visits following the guidelines developed by all member hospitals, making the Colloquium's approach to accreditation unique in America. The site reviewers were Frank W. Smart, MD, FACC, (Colloquium Board Chair) and Sonja H. Dahl, DNP, RN, CPNP, (Heart Failure Leadership Team Coordinator at Mayo Clinic in Rochester, Minnesota). 
For more information, visit:

Related Content

New Target for Treating Heart Failure Identified by Penn Medicine Researchers

Microtubules in heart cells from a healthy patient (left) and from a patient with heart failure. The dense network of detyrosinated microtubules impedes the motion of the failing heart cell during the heart beat. Credit: Ben Prosser lab, Perelman School of Medicine, University of Pennsylvania

News | Heart Failure | June 25, 2018
New research finds changes in cellular struts called microtubules (MT) can affect the stiffness of diseased human heart...
Gencaro Does Not Reduce Atrial Fibrillation Risk in Heart Failure Patients
News | Heart Failure | May 30, 2018
Data from the GENETIC-AF trial was presented in a “Late Breaking Clinical Trials” oral presentation at the European...
Cardiac Contractility Modulation Safe and Effective as Heart Failure Treatment

Image courtesy of Impulse Dynamics

News | Heart Failure | May 18, 2018
In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve exercise...
V-Wave Closes $70M Financing to Support Pivotal Study of Heart Failure Therapy
News | Heart Failure | May 16, 2018
Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally invasive...
News | Heart Failure | May 14, 2018
Ancora Heart Inc. announced the expansion of the company’s U.S. feasibility study to evaluate the investigational...
Protein Clumping May Contribute to Heart Failure Development

A PET scan detects clumping proteins in rat hearts (top). The enlarged heart (right) is one with heart failure. Other PET scans showing blood flow in the rat hearts (bottom) show that the protein clumps aren't due to circulation problems. Image courtesy of Circulation Research, May 11, 2018.

News | Heart Failure | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
Minnesota Living With Heart Failure Questionnaire Qualified for FDA Medical Device Development Tools Program

The CORolla device from Israel-based CorAssist is one example of new devices being manufactured and tested to treat heart failure. The efficacy of this and other new devices under development can now be assessed with the Minnesota Living With Heart Failure Questionnaire. 

Technology | Heart Failure | May 07, 2018
The U.S. Food and Drug Administration (FDA) has qualified the Minnesota Living with Heart Failure Questionnaire from...
Nation's First Heart Failure and Arrhythmia Center Opening in Ohio

Image courtesy of The Ohio State University

News | Heart Failure | April 04, 2018
The Ohio State University Wexner Medical Center will establish the nation’s first center dedicated to treating those...
Abbott Initiates GUIDE-HF Trial for Improved Outcomes With CardioMEMS Monitor
News | Heart Failure | March 29, 2018
Abbott announced the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS HF System. The...
Videos | Heart Failure | March 23, 2018
David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit, d
Overlay Init